Report of Foreign Issuer (6-k)
November 08 2013 - 4:08PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2013
Commission File Number: 001-34541
CHINA
CORD BLOOD CORPORATION
(Translation of registrant’s name
into English)
48
th
Floor, Bank of China Tower
1 Garden Road
Central
Hong Kong
S.A.R.
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F
x
Form
40-F
¨
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
¨
Indicate by check mark if the registrant is submitting the
Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
¨
Indicate by check mark whether the registrant by furnishing
the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b)
under the Securities Exchange Act of 1934.
Yes
¨
No
x
If “Yes” is marked, indicate below the file number
assigned to the registrant in connection with Rule 12g3-2(b): 82-_______________.
This report and each of the exhibits to this report are
hereby incorporated by reference into the registration statements on Form F-3 (No. 333-168873, No. 333-183143 and No. 333-191121)
of the Company.
Other Events
Attached hereto as Exhibit 99.1 is a Notice
of Annual General Meeting of Shareholders and Proxy Statement and Form of Proxy of China Cord Blood Corporation (the “Company”)
relating to the Company’s 2013 Annual General Meeting.
Where to Find Additional Information
The Company is a foreign private issuer.
As such, the proxy statement is not subject to review and comment by the Securities and Exchange Commission (the “SEC”).
Shareholders are urged to carefully read
the proxy statement, because it contains important information about the Company and the 2013 Annual General Meeting of Shareholders.
Copies of the proxy statement and other documents filed or submitted by the Company will be available at the website maintained
by the SEC at www.sec.gov. Shareholders may obtain a copy of such filings and the Company’s annual report, free of charge,
from the Company’s website at www.chinacordbloodcorp.com, by contacting our Investor Relations Department at: ir@chinacordbloodcorp.com
or by writing to us at 48
th
Floor, Bank of China Tower, 1 Garden Road, Central, Hong Kong S.A.R., ATTN: Secretary.
Participants in the Solicitation
The Company and its directors and executive
officers may be deemed to be participants in the solicitation of proxies from the shareholders of the Company in connection with
the 2013 Annual General Meeting of Shareholders. Information regarding certain directors and executive officers of the Company
is available in the Company’s documents filed with or submitted to the SEC. Other information regarding the participants
in the proxy solicitation and descriptions of their direct and indirect interests, by security holdings or otherwise, are set forth
in the proxy statement filed herewith.
Exhibits
Exhibit No.
|
Description
|
99.1
|
Notice of Annual General Meeting of Shareholders, Proxy Statement and Form of Proxy
|
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
CHINA CORD BLOOD CORPORATION
|
|
By:
|
/s/ Albert Chen
|
|
Name:
|
Albert Chen
|
|
Title:
|
Chief Financial Officer
|
Dated: November 8, 2013
Global Cord Blood (NYSE:CO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Global Cord Blood (NYSE:CO)
Historical Stock Chart
From Jul 2023 to Jul 2024